<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03966417</url>
  </required_header>
  <id_info>
    <org_study_id>UKCLFitTAVI</org_study_id>
    <nct_id>NCT03966417</nct_id>
  </id_info>
  <brief_title>Exercise Training After Transcatheter Aortic Valve Implantation</brief_title>
  <acronym>FitTAVI</acronym>
  <official_title>Exercise Training After Transcatheter Aortic Valve Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Centre Ljubljana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Centre Ljubljana</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective, controlled trial, patient after TAVI will be randomized to either
      exercise training or usual care group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients after transcatheter aortic valve replacement (TAVI) are particularly old and
      severely deconditioned and are thus likely to benefit from cardiac rehabilitation programs.
      In this controlled trial, patients after TAVI will be randomized to either exercise training
      or usual care.

      The aim of our study is to compare the effect of exercise training vs. usual care on:

        1. exercise capacity

        2. vascular function

        3. parameters of heart failure, inflammation and homeostasis

        4. arrhythmogenic potential

        5. health-related quality of life
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 18, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of maximal oxygen uptake during exercise</measure>
    <time_frame>3 months</time_frame>
    <description>ml/kg/min</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of flow-mediated dilatation (FMD) of the brachial artery</measure>
    <time_frame>3 months</time_frame>
    <description>% flow-mediated dilatation and arterial stiffness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of arterial stiffness coefficient</measure>
    <time_frame>3 months</time_frame>
    <description>coefficient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of value of blood N terminal-proBNP</measure>
    <time_frame>3 months</time_frame>
    <description>ng/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of value of blood D-dimer</measure>
    <time_frame>3 months</time_frame>
    <description>microg/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of value from-the-questionnaire-obtained quality of life</measure>
    <time_frame>3 months</time_frame>
    <description>points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of ECG waves</measure>
    <time_frame>3 months</time_frame>
    <description>Estimated with digital high-resolution ECG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the result of the 6-minute walking test</measure>
    <time_frame>3 months</time_frame>
    <description>metres</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change og the heart rate variability</measure>
    <time_frame>3 months</time_frame>
    <description>Estimated with digital high-resolution ECG</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change of heart rate recovery</measure>
    <time_frame>3 months</time_frame>
    <description>beats/min</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <condition>TAVI</condition>
  <condition>Transcatheter Aortic Valve Implantation</condition>
  <condition>Rehabilitation</condition>
  <arm_group>
    <arm_group_label>Exercise training group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient to be randomized to &quot;exercise training group&quot; will have exercise training sessions 2 times per week for a period of 12 weeks. They will undergo moderate continuous exercise training at 75% of Vo2max.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patient to be randomized to &quot;usual care group&quot; will undergo standard care fo 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise training</intervention_name>
    <description>Continuous exercise training 2 times per week for a period of 12 weeks.</description>
    <arm_group_label>Exercise training group</arm_group_label>
    <other_name>Rehabilitation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  TAVI procedure 3-6 months prior to inclusion,

          -  movability (100 meters or more on 6-minute walking test after TAVI),

          -  ability to attend a 12 week exercise training program,

          -  physical and clinical ability to attend the rehabilitation program at the discretion
             of the researcher,

          -  optimal medical treatment,

          -  pre-signed statement of a conscious and free consent to the inclusion in the clinical
             trial.

        Exclusion Criteria:

          -  contraindications for exercise training,

          -  unstable hearth (uncontrollable heart failure - New York Heart Association stage IV,
             dysrhythmias, uncontrollable myocardial ischemia),

          -  patient's decision to undergo TAVI despite receiving a recommendation for Surgical
             Aortic Valve Repair by the heart team,

          -  non-cardiac physical impairment that would prevent exercise training on stationary
             bike,

          -  uncontrolled pulmonary disease (FEV1 &lt;50%),

          -  echocardiographic signs of prosthesis dysfunction according to the Valve Academic
             Research Consortium (valve orifice area of b1.2 cm2 plus a mean transaortic pressure
             gradient of ≥20 mm Hg, or a velocity of ≥3 m/s, at least moderate paravalvular
             regurgitation),

          -  TAVI access site complication,

          -  important peripheral vascular disease, musculoskeletal disease or central nervous
             system disease, which prevents exercise training on stationary bike,

          -  recent (less than 3 months) acute events or illnesses that are contraindications for
             exercise training.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Borut Jug, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Centre Ljubljana, Slovenia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luka Vitez, MD</last_name>
    <phone>+38641951672</phone>
    <email>luka.vitez@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Borut Jug, MD, PhD</last_name>
    <email>borut.jug@kclj.si</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UMC Ljubljana</name>
      <address>
        <city>Ljubljana</city>
        <zip>1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Borut Jug, PhD</last_name>
      <email>borut.jug@kclj.si</email>
    </contact>
    <investigator>
      <last_name>Luka Vitez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <reference>
    <citation>Chakos A, Wilson-Smith A, Arora S, Nguyen TC, Dhoble A, Tarantini G, Thielmann M, Vavalle JP, Wendt D, Yan TD, Tian DH. Long term outcomes of transcatheter aortic valve implantation (TAVI): a systematic review of 5-year survival and beyond. Ann Cardiothorac Surg. 2017 Sep;6(5):432-443. doi: 10.21037/acs.2017.09.10. Review.</citation>
    <PMID>29062738</PMID>
  </reference>
  <reference>
    <citation>Pressler A, Christle JW, Lechner B, Grabs V, Haller B, Hettich I, Jochheim D, Mehilli J, Lange R, Bleiziffer S, Halle M. Exercise training improves exercise capacity and quality of life after transcatheter aortic valve implantation: A randomized pilot trial. Am Heart J. 2016 Dec;182:44-53. doi: 10.1016/j.ahj.2016.08.007. Epub 2016 Aug 26.</citation>
    <PMID>27914499</PMID>
  </reference>
  <reference>
    <citation>Dalal HM, Doherty P, Taylor RS. Cardiac rehabilitation. BMJ. 2015 Sep 29;351:h5000. doi: 10.1136/bmj.h5000. Review.</citation>
    <PMID>26419744</PMID>
  </reference>
  <reference>
    <citation>McMahon SR, Ades PA, Thompson PD. The role of cardiac rehabilitation in patients with heart disease. Trends Cardiovasc Med. 2017 Aug;27(6):420-425. doi: 10.1016/j.tcm.2017.02.005. Epub 2017 Feb 15. Review.</citation>
    <PMID>28318815</PMID>
  </reference>
  <reference>
    <citation>Butchart EG, Gohlke-Bärwolf C, Antunes MJ, Tornos P, De Caterina R, Cormier B, Prendergast B, Iung B, Bjornstad H, Leport C, Hall RJ, Vahanian A; Working Groups on Valvular Heart Disease, Thrombosis, and Cardiac Rehabilitation and Exercise Physiology, European Society of Cardiology. Recommendations for the management of patients after heart valve surgery. Eur Heart J. 2005 Nov;26(22):2463-71. Epub 2005 Aug 15.</citation>
    <PMID>16103039</PMID>
  </reference>
  <reference>
    <citation>Völler H, Salzwedel A, Nitardy A, Buhlert H, Treszl A, Wegscheider K. Effect of cardiac rehabilitation on functional and emotional status in patients after transcatheter aortic-valve implantation. Eur J Prev Cardiol. 2015 May;22(5):568-74. doi: 10.1177/2047487314526072. Epub 2014 Feb 27.</citation>
    <PMID>24577878</PMID>
  </reference>
  <reference>
    <citation>Russo N, Compostella L, Tarantini G, Setzu T, Napodano M, Bottio T, D'Onofrio A, Isabella G, Gerosa G, Iliceto S, Bellotto F. Cardiac rehabilitation after transcatheter versus surgical prosthetic valve implantation for aortic stenosis in the elderly. Eur J Prev Cardiol. 2014 Nov;21(11):1341-8. doi: 10.1177/2047487313494029. Epub 2013 Jun 11.</citation>
    <PMID>23757283</PMID>
  </reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>May 25, 2019</study_first_submitted>
  <study_first_submitted_qc>May 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 29, 2019</study_first_posted>
  <last_update_submitted>June 18, 2019</last_update_submitted>
  <last_update_submitted_qc>June 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Centre Ljubljana</investigator_affiliation>
    <investigator_full_name>Borut Jug</investigator_full_name>
    <investigator_title>prof. Borut Jug, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>exercise training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

